Evidence map›Paper›PMID 39271744›Full record

ArticleCommunications biology2024

Ligand requirements for immunoreceptor triggering.

Michael I Barton, Rachel L Paterson, Eleanor M Denham, Jesse Goyette, Philip Anton van der Merwe

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael I BartonSir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Rachel L PatersonSir William Dunn School of Pathology, University of Oxford, Oxford, UK.ORCID 0000-0001-6268-5947
Eleanor M DenhamSir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Jesse Goyette *Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.ORCID 0000-0002-1008-1890
Philip Anton van der Merwe *Sir William Dunn School of Pathology, University of Oxford, Oxford, UK. anton.vandermerwe@path.ox.ac.uk.ORCID 0000-0001-9902-6590

Funding

Wellcome Trust (Wellcome) 101799/Z/13/Z
6 · The paper itself

Abstract

Leukocytes interact with other cells using cell surface receptors. The largest group of such receptors are non-catalytic tyrosine phosphorylated receptors (NTRs), also called immunoreceptors. NTR signalling requires phosphorylation of cytoplasmic tyrosine residues by SRC-family tyrosine kinases. How ligand binding to NTRs induces this phosphorylation, also called NTR triggering, remains controversial, with roles suggested for size-based segregation, clustering, and mechanical force. Here we exploit a recently developed cell-surface generic ligand system to explore the ligand requirements for NTR triggering. We examine the effect of varying the ligand's length, mobility and valency on the activation of representative members of four NTR families: SIRPβ1, Siglec 14, NKp44 and TREM-1. Increasing the ligand length impairs activation via NTRs, despite enhancing cell-cell conjugation, while varying ligand mobility has little effect on either conjugation or activation. Increasing the valency of the ligand, while enhancing cell-cell conjugation, does not enhance activation at equivalent levels of conjugation. These findings are more consistent with a role for size-based segregation, rather than mechanical force or clustering, in NTR triggering, suggesting a role for the kinetic-segregation model.

Indexed as

Receptors, ImmunologicHumansLigandsPhosphorylationSignal TransductionLigandsReceptors, Immunologic

Identifiers

PMID39271744
PMCPMC11399299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.